1. Selection of patients with hepatocellular carcinoma for sorafenib;Abou-Alfa;J Natl Compr Canc Netw,2009
2. TACE and sorafenib: a good marriage?;Abou-Alfa;J Clin Oncol,2011
3. Safety and efficacy of sorafenib in patients with hepatocellular carcinoma (HCC) and Child-Pugh A versus B cirrhosis;Abou-Alfa;Gastrointest Cancer Res,2011
4. A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma;Abou-Alfa;J Hepatol,2014
5. Association of dynamic contrast enhanced-MRI (DCE-MRI) with response in a subgroup of patients with advanced hepatocellular carcinoma (HCC) treated with doxorubicin plus sorafenib [abstract 271];Abou-Alfa,2009